Invention Grant
![N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof](/docs/US/2021-06-01/US11021474B2/abs.jpg.600x600.jpg)
- Patent Title: N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof
-
Application No.: US16464448Application Date: 2017-11-28
-
Publication No.: US11021474B2Publication Date: 2021-06-01
- Inventor: Yogeshwar Bachhav , Wilfried Schwab , Alexander Birkmann , Kurt Voegtli
- Applicant: AiCuris Anti-Infective Cures GmbH
- Applicant Address: DE Wuppertal
- Assignee: AiCuris Anti-Infective Cures GmbH
- Current Assignee: AiCuris Anti-Infective Cures GmbH
- Current Assignee Address: DE Wuppertal
- Agency: Millen White Zelano and Branigan, PC
- Agent John Sopp
- Priority: EP16200967 20161128
- International Application: PCT/EP2017/080653 WO 20171128
- International Announcement: WO2018/096170 WO 20180531
- Main IPC: A61K31/427
- IPC: A61K31/427 ; A61K31/4439 ; C07D417/12 ; C07D417/10 ; A61P31/22
![N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof](/abs-image/US/2021/06/01/US11021474B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to the field of anti-viral active agents, particularly the free base hemihydrate form of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide as well as methods for the manufacture thereof. The present invention relates also to the use of the above compound in the treatment of human herpes virus infections and in the preparation of pharmaceuticals comprising said compound.
Information query
IPC分类:
